SCHEMBL15211586

SCHEMBL15211586

CCCCC/C=C\CCCCCCCC/C=C/CCC(CCCC/C=C/CCCCC)OC(=O)CCCCCN(C)C

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 2/20 0.55
PRKCE Q02156 1/20 0.55
PRKCQ Q04759 1/20 0.55
PRKCD Q05655 1/20 0.55
MAPT P10636 2/20 0.52
ALDH1A1 P00352 2/20 0.52
FAAH O00519 1/20 0.52
HPGD P15428 1/20 0.52
CNR1 P21554 1/20 0.52
CNR2 P34972 1/20 0.52
SLC6A5 Q9Y345 1/20 0.51
LPAR1 Q92633 1/20 0.50
DAGLA Q9Y4D2 2/20 0.48
S1PR1 P21453 1/20 0.48
MAPK1 P28482 1/20 0.48
EPHX2 P34913 3/20 0.47
DNM1 Q05193 1/20 0.46
LMNA P02545 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15211803 1.00 PRKCA (0.55) PRKCAPRKCEPRKCQPRKCDMAPT
SCHEMBL17502440 1.00 PRKCA (0.55) PRKCAPRKCEPRKCQPRKCDMAPT
SCHEMBL24450239 0.97 PRKCA (0.57) PRKCAPRKCEPRKCQPRKCDMAPT
SCHEMBL19991254 0.96 MAPT (0.53) PRKCAPRKCEPRKCQPRKCDMAPT
SCHEMBL15211946 0.96 MAPT (0.53) PRKCAPRKCEPRKCQPRKCDMAPT
SCHEMBL25514871 0.96 PRKCA (0.56) PRKCAPRKCEPRKCQPRKCDMAPT
SCHEMBL27306508 0.95 PRKCA (0.57) PRKCAPRKCEPRKCQPRKCDMAPT
SCHEMBL15211587 0.94 PRKCA (0.50) PRKCAPRKCEPRKCQPRKCDMAPT
SCHEMBL21235517 0.94 ALDH1A1 (0.61) PRKCAPRKCEPRKCQPRKCDMAPT
SCHEMBL21373214 0.94 ALDH1A1 (0.61) PRKCAPRKCEPRKCQPRKCDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2817287-A1 TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF Protiva Biotherapeutics Inc. (CA) 2014-12-31 EP disclosed
WO-2013126803-A1 TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF PROTIVA BIOTHERAPEUTICS INC. (CA) 2013-08-29 WO disclosed